138499-08-8 Usage
Description
(3S)-TETRAHYDROFURANYLSUCCINIMIDYL-CARBONATE, also known as Carbonic Acid 2,5-Dioxopyrrolidin-1-yl (S)-Tetrahydrofuran-3-yl Ester, is an off-white solid compound with the CAS number 138499-08-8. It is a versatile compound used in various organic synthesis processes due to its unique chemical properties.
Uses
Used in Organic Synthesis:
(3S)-TETRAHYDROFURANYLSUCCINIMIDYL-CARBONATE is used as a synthetic building block for the creation of various organic compounds. Its unique structure allows it to be a valuable intermediate in the synthesis of complex molecules, particularly in the pharmaceutical and chemical industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (3S)-TETRAHYDROFURANYLSUCCINIMIDYL-CARBONATE is used as a key component in the development of new drugs. Its ability to form complex molecular structures makes it an essential tool in the design and synthesis of novel therapeutic agents.
Used in Chemical Industry:
(3S)-TETRAHYDROFURANYLSUCCINIMIDYL-CARBONATE is also utilized in the chemical industry for the production of specialty chemicals and materials. Its versatility in organic synthesis allows for the creation of a wide range of products, from advanced materials to fine chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 138499-08-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,4,9 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 138499-08:
(8*1)+(7*3)+(6*8)+(5*4)+(4*9)+(3*9)+(2*0)+(1*8)=168
168 % 10 = 8
So 138499-08-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO6/c11-7-1-2-8(12)10(7)16-9(13)15-6-3-4-14-5-6/h6H,1-5H2/t6-/m0/s1
138499-08-8Relevant articles and documents
COMPOSITION FOR TREATMENT AND/OR PREVENTION OF PERIPHERAL NERVE DISORDER
-
Paragraph 0153, (2019/10/29)
The present invention provides a means for treating and/or preventing peripheral nerve disorder by facilitating regeneration of peripheral nerves. Specifically, the present invention provides a composition for treating and/or preventing peripheral nerve d
Lissencephaly therapeutic agent
-
Page/Page column 31, (2016/07/27)
An object of the present invention is to provide a medicament and method for treating lissencephaly patients. The present invention provides a lissencephaly therapeutic or preventive agent comprising a compound represented by the general formula (I): wher
A PROCESS FOR SYNTHESIS OF SYN AZIDO EPOXIDE AND ITS USE AS INTERMEDIATE THE SYNTHESIS OF AMPRENAVIR and SAQUINAVIR
-
Page/Page column 23-24, (2013/07/25)
Disclosed herein is a novel route of synthesis of syn azide epoxide of formu 5, which is used as a common intermdeiate for asymmetric synthesis of HIV protease inhibitors such as Amprenavir, Fosamprenavir, Saquinavir and formal synthesis of Darunavir and